Greater development of 1,2-dimethylhydrazine-induced colon cancer in a rat model of type 2 diabetes mellitus

Journal of International Medical Research

Volumn 34, Issue 4, 2006, Pages 385-389

  Terai, K ^a   Sakamoto, K ^a   Goto, M ^a   Matsuda, M ^a   Kasamaki, S ^a   Shinmura, K ^a   Takita, N ^a   Kamano, T ^a  

^a JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

1,2 Dimethylhydrazine; Carcinogens; Colon cancer; Rat model; Type 2 diabetes mellitus

Indexed keywords

1,2 DIMETHYLHYDRAZINE; CARCINOGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOPSY; CANCER GROWTH; CANCER INVASION; CARCINOGENESIS; COLON CANCER; CONTROLLED STUDY; HISTOPATHOLOGY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; RAT; STATISTICAL SIGNIFICANCE;

EID: 33748573257     PISSN: 03000605     EISSN: None     Source Type: Journal    
DOI: 10.1177/147323000603400407     Document Type: Article

References (15)

1. Kono S, Honjo S, Todoroki I, Nishiwaki M, Hamada H, Nishikawa H, et al: Glucose intolerance and adenomas of the sigmoid colon in Japanese men (Japan). Cancer Causes Control 1998; 9: 441-446.
2. Will JC, Galuska DA, Vinicor F, Calle EE: Another complication of diabetes mellitus? Am J Epidemiol 1998; 147: 816-825.
3. Hu FB, Manson JE, Liu S, Hunter D, Colditz GA, Michels KB, et al: Prospective study of adult onset diabetes mellitus (type 2) and risk of colorectal cancer in women. J Natl Cancer Inst 1999; 91: 542-547.
4. Schoen RE, Tangan CM, Kuller LH, Hunter D, Colditz GA, Michels KB, et al: Increased blood glucose and insulin, body size, and incident colorectal cancer. J Natl Cancer Inst 1999; 91: 1147-1154.
5. Yamada K, Araki S, Tamura M, Sakai I, Takahashi Y, Kashihara H, et al: Relation of serum total cholesterol, serum triglycerides and fasting plasma glucose to colorectal carcinoma in situ. Int J Epidemiol 1998; 27: 794-798.
6. Kaaks R, Toniolo P, Akhmedkhanov A, Lukanova A, Biessy C, Dechaud H, et al: Serum C-peptide, insulin-like growth factor (IGF)-I, IGF-binding proteins, and colorectal cancer risk in women. J Natl Cancer Inst 2000; 92: 1592-1600.
7. Saydah SH, Lorita CH, Eberhardt MS, Brancati FL: Abnormal glucose tolerance and the risk of cancer death in the United States. Am J Epidemiol 2003; 157: 1092-1100.
8. Limburg PJ, Anderson KE, Johnson TW, Jacobs DR Jr, Lazovich D, Hong CF, et al: Diabetes mellitus and subsite-specific colorectol cancer risk in the Iowa Women's Health Study. Cancer Epidemiol Biomarker Prev 2005; 14: 133-137.
9. Wei EK, Ma J, Pollak MN, Rifai N, Fuchs CS, Hankinson SE, et al: A prospective study of C-peptide, insulin-like growth factor-I, insulin-like growth factor binding protein-1, and the risk of colorectal cancer in women. Cancer Epidemiol Biomarker Prev 2005; 14: 850-855.
10. Kawano K, Hirashima T, Mori S, Saitou Y, Kurosumi M, Natori T: Spontaneous long-term hyperglycemic rat with diabetic complications. Diabetes 1992; 41: 1422-1428.
11. Giovannuci E: Insulin and colon cancer. Cancer Causes Control 1995; 6: 164-179.
12. Corpet DE, Jacquinet C, Peiffer G, Tache S: Insulin injections promote the growth of aberrant crypt foci in the colon of rats. Nutr Cancer 1997; 27: 316-320.
13. Tran IT, Medline A, Bruce WR: Insulin promotion of colon tumors in rats. Cancer Epidemiol Biomarker Prev 1996; 5: 1013-1015.
14. Giovannucci E: Insulin, insulin-like growth factors and colon cancer: a review of the evidence. J Nutr 2001; 131: 3109S-3120S.
15. Sandhu MS, Dunger DB, Giovannucci EL: Insulin, insulin-like growth factor-I (IGF-1), IGF binding proteins, their biologic interactions, and colorectal cancer. J Natl Cancer Inst 2002; 94: 972-980.